The Legacy of CVI

Marcela F Pasetti; Steven D Douglas; Susan F Plaeger

doi:10.1128/CVI.00276-17

The Legacy of CVI

Clin Vaccine Immunol. 2017 Dec 5;24(12):e00276-17. doi: 10.1128/CVI.00276-17. Print 2017 Dec.

Authors

Marcela F Pasetti¹, Steven D Douglas², Susan F Plaeger³

Affiliations

¹ Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, Maryland, USA mpasetti@som.umaryland.edu.
² Department of Pediatrics, Division of Allergy-Immunology, Children's Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
³ Basic Sciences Program, Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.

Abstract

Clinical and Vaccine Immunology (CVI) will merge with the American Society for Microbiology (ASM) open-access journal mSphere in January 2018. We commemorate this transition by exploring the history of CVI and that of its predecessor, Clinical and Diagnostic Laboratory Immunology (CDLI), and by acknowledging their contributors. Research on vaccines, clinical immunology, and clinical diagnostic immunology published through mSphere will be available without restrictions to an ever-larger audience, which will expedite progress in the field. ASM remains committed to supporting its members and the research community by facilitating the dissemination of scientific knowledge in these important areas.

Keywords: vaccines.

Publication types

Editorial

MeSH terms

Animals
Editorial Policies*
Humans
Immunoassay / methods*
Immunotherapy / methods*
Periodicals as Topic*